YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Paxil Birth Defects


AddThis Social Bookmark Button

Paxil Birth Defect Lawsuit / Lawyers

The lawyers and attorneys at our firm are currently representing families of children who have suffered Paxil birth defects.  In 2005, the Food & Drug Administration (FDA) warned that the antidepressant Paxil had been linked to an increased risk of birth defects, and asked GlaxoSmithKline to modify the drug's labeling to reflect this risk.  The Paxil birth defect risk is especially high if an expectant mother took Paxil during the first trimester of pregnancy.  If you or someone you know was the victim of Paxil side effects, we urge you to contact one of our Paxil injury lawyers as soon as possible.

Paxil - known generically as paroxetine - was brought to market by GlaxoSmithKline in 1992, and by 2006, Paxil was the fifth most-commonly prescribed antidepressant in the US, with more than 19.7 million prescriptions.   Paxil was approved by the FDA to treat symptoms of depression, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), panic disorder, generalized anxiety disorder (GAD), social phobia/social anxiety disorder, and premenstrual dysphoric disorder (PMDD). Paxil was the first antidepressant formally approved in the US for the treatment of social anxiety disorder.

 
Paxil is part of a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs).  SSRIs affect seratonin levels in the brain, a chemical neurotransmitter.  Seratonin is produced in the brain on an ongoing basis and in response to pleasure-giving experiences, in a normally healthy system. SSRIs like Paxil have been linked to an increased risk of suicide when they are taken by young people.  In addition to investigating claims for Paxil birth defects, our Paxil injury lawyers are also offering free evaluations to victims of other Paxil side effects, including suicidal behavior.

 
FDA Paxil Birth Defect Warnings

In September 2005, the FDA and GlaxoSmithKline alerted doctors about a new study on major birth defects seen in babies born to women who took the antidepressant Paxil during the first trimester of pregnancy.  The alert was based on a study GlaxoSmithKline conducted of major birth defects in infants born to women who took antidepressants  - including Paxil - during the first trimester of pregnancy.

In the study of more than 3,500 pregnant women, Paxil was linked to twice as many major birth defects as other antidepressants, according to the FDA.  Most of the birth defects seen in the study were heart related; the most common heart malformations were ventricular septal defects, which are holes between the heart's two main pumping chambers.  The FDA said GlaxoSmithKline would be updating the Paxil precautions section to include data from this study.

In December 2005, the FDA announced that it was requiring GlaxoSmithKline to add additional warnings about Paxil birth defects to the drug's prescribing information.  The FDA took the action because the early results of two more studies showed that women who took Paxil during the first three months of pregnancy were about one and a half to two times as likely to have a baby with a heart defect as women who received other antidepressants or women in the general population. Most of the heart defects reported in these studies were atrial and ventricular septal defects (holes in the walls of the chambers of the heart).  In general, these types of defects ranged in severity from those that were minor and resolved without treatment to those that caused serious symptoms and needed to be repaired surgically.
 

The FDA said in one of the studies, the risk of heart defects in babies whose mothers had taken Paxil early in pregnancy was about 2 percent, compared to a 1 percent risk in the whole population. In the other study, the risk of heart defects in babies whose mothers had taken Paxil in the first three months of pregnancy was 1.5 percent, compared to 1 percent in babies whose mothers had taken other antidepressants in the first three months of pregnancy.

The Paxil label was again changed to reflect the latest data from the two studies and to change the pregnancy category.  The FDA had previously classified the Paxil birth defect  risk as Category C (Risk of Fetal Harm Cannot be Ruled Out).  The new Paxil labeling now classified the birth defect risk as Category D (Positive Evidence of Fetal Risk).

 

The FDA advised health care professionals to discuss the potential risk of birth defects with patients taking Paxil who plan to become pregnant or are in their first three months of pregnancy. The agency also said health care professionals should consider discontinuing Paxil (and switching to another antidepressant if indicated) in these patients.

The FDA also cautioned patients that Paxil should usually not be taken during pregnancy. Women taking Paxil who were pregnant or planned to become pregnant were advised to talk to their physicians about the potential risks of taking the drug during pregnancy.  However, the FDA also said women taking Paxil should not stop taking it without first talking with their physician.

Legal Help for Victims of Paxil Related Birth Defects

If you know a child who has suffered from Paxil birth defects, or if you or someone you know experienced other serious side effects because of Paxil, we urge you call our law firm immediately. Our experienced Paxil side effects lawyers can make sure you or your loved one is compensated for your injuries.  Please fill out our online form or call us at 1-800 LAW INFO (1-800-529-4636) for a free review of your case.

Paxil Birth DefectsRSS Feed

Mildly Depressed Patients Not Helped Much by Antidepressants

Jan 6, 2010 | Parker Waichman Alonso LLP
The wisdom of treating mildly depressed people with antidepressants like Paxil is being questioned by a new study published in the Journal of the American Medical Association (JAMA). In the U.S., antidepressants are used by nearly 15 million adults every year.   Many of these patients fall into the mild or moderately depressed category, yet few studies have been conducted on the effectiveness of antidepressants on such patients.  Most studies - including those used to assess a...

Paxil Lawsuit Settlements Amount to $1 Billion So Far

Dec 14, 2009 | Parker Waichman Alonso LLP
Paxil lawsuit settlements have been detailed in a report on Bloomberg.com.  According to court papers and other sources, GlaxoSmithKline has paid about $1 billion to settle Paxil lawsuits involving suicide, birth defects and other issues.Those settlements include  about 10 birth-defect cases, for an average of $4 million each, Bloomberg.com said.   About 600 more Paxil birth defect cases remain, and at least one analyst has written that “a liability totaling $1.5...

Glaxo Faces More Paxil Birth Defect Lawsuits

Dec 11, 2009 | Parker Waichman Alonso LLP
GlaxoSmithKline has been hit with three more Paxil birth defect lawsuits, this time in Texas.Paxil is one of a class of drugs known as selective serotonin reuptake inhibitors (SSRI). On two occasions in 2005, the Food & Drug Administration (FDA) requested that the labeling of Paxil be changed to include warnings on three studies that found an increase risk of birth defects. Most of the heart defects reported in these studies were atrial and ventricular septal defects (holes in the walls of...

First Paxil Birth Defects Trial A Loss for Glaxo

Oct 14, 2009 | Parker Waichman Alonso LLP
GlaxoSmithKline has lost the first Paxil birth defects lawsuit to go to trial, with a Pennsylvania state jury ordering the drug maker to pay $2.5 million to the family of a 3-year-old boy.  The child was born with heart defects, which his mother attributed to her use of Paxil while pregnant with him.Paxil is one of a class of drugs known as selective serotonin reuptake inhibitors (SSRI). On two occasions in 2005, the Food & Drug Administration (FDA) requested that the labeling of Paxil...

SSRI Antidepressants Linked to Early Birth

Oct 6, 2009 | Parker Waichman Alonso LLP
Women who take antidepressants known as selective serotonin reuptake inhibitors or SSRIs during pregnancy may be more likely to experience  premature birth than other women, according to a new study.    The study, which was published in the  Archives of Pediatrics and Adolescent Medicine, also found that babies born to women taking SSRIs were more likely to be admitted to an intensive care unit.Popular SSRIs include Prozac, Paxil, Zoloft, Celexa, and Lexapro. ...

More Paxil Birth Defects News

Paxil Birth Defects
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

* Date Of Birth Of The Person Taking Paxil (mm-dd-yyyy)

* Date Of Birth Of Child With Birth Defect (mm-dd-yyyy)

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Were You Taking Paxil During The First 3 Months of Pregnancy


What Type Of Birth Defect Did The Child Sustain

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2010 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising